Cargando…
Chemotherapeutic Activity of Pitavastatin in Vincristine Resistant B-Cell Acute Lymphoblastic Leukemia
SIMPLE SUMMARY: Chemoresistance leads to poor prognostic outcomes in leukemic patients. Investigating the effects of pitavastatin in chemo-resistant ALL cells provides support for repurposing this FDA-approved drug to contribute to novel interventions to eradicate residual tumor cells that thrive in...
Autores principales: | Piktel, Debbie, Moore, Javohn C., Nesbit, Sloan, Sprowls, Samuel A., Craig, Michael D., Rellick, Stephanie L., Nair, Rajesh R., Meadows, Ethan, Hollander, John M., Geldenhuys, Werner J., Martin, Karen H., Gibson, Laura F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913300/ https://www.ncbi.nlm.nih.gov/pubmed/36765664 http://dx.doi.org/10.3390/cancers15030707 |
Ejemplares similares
-
Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia
por: Piktel, Debbie, et al.
Publicado: (2022) -
Co-culture model of B-cell acute lymphoblastic leukemia recapitulates a transcription signature of chemotherapy-refractory minimal residual disease
por: Rellick, Stephanie L., et al.
Publicado: (2021) -
Bone Marrow Osteoblast Damage by Chemotherapeutic Agents
por: Rellick, Stephanie L., et al.
Publicado: (2012) -
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia
por: Raj, Trisha A Soosay, et al.
Publicado: (2013) -
Carboplatin Plus Vincristine as an Alternative Chemotherapeutic Scheme in Patients With Glioblastoma
por: Sangrador-Deitos, Marcos V, et al.
Publicado: (2022)